[HTML][HTML] Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It

C Ma, S McClean - Vaccines, 2021 - mdpi.com
Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …

[HTML][HTML] Carbapenamase-producing Acinetobacter baumannii in China, Latin America and the Caribbean: A systematic review and meta-analysis

H Yu, G Ezpeleta-Lobato, X Han… - MEDICC …, 2022 - SciELO Public Health
INTRODUCTION Carbapenem-resistant Acinetobacter baumannii is a complex health
problem, causing difficulties in clinical–therapeutic management worldwide. It is of particular …

Immunization with recombinant DcaP-like protein and AbOmpA revealed protections against sepsis infection of multi-drug resistant Acinetobacter baumannii ST2Pas …

S Fereshteh, S Ajdary, A Sepehr, N Bolourchi… - Microbial …, 2023 - Elsevier
Backgrounds The prevalence of infections associated with multi-drug resistant (MDR)
Acinetobacter baumannii is increasing worldwide. Therefore, the introduction of effective …

[HTML][HTML] The occurrence and characterization of class i, ii, and iii integrons among carbapenemase-producing clinical strains of Acinetobacter baumannii in Tehran …

O Azizi, S Fereshteh, O Nasiri, M Ghorbani… - Jundishapur Journal of …, 2021 - brieflands.com
Background: Acinetobacter baumannii has emerged as a critical pathogen with high
morbidity and mortality in long-term hospitalized patients who stay in intensive care units …